Lupus Research Institute Awards Wide-Ranging Research Grants to Drive Next Generation of Scientific Discovery in Lupus
Commits $3.6 million for innovative studies to find new solutions for devastating disease with limited treatment options
Today we announce the award of 12 new research grants, building on our decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world’s most confounding and elusive diseases – lupus.
Awarded for the highest-ranked creative new science, the grants span a range of topics and multi-disciplinary approaches that mirror the heterogeneity and complexity of the disease. Investigators from across the country will explore how the regulation of the immune system goes awry in lupus, how to better understand the immunological attack, and how the process can be manipulated therapeutically to correct specific manifestations that produce the tissue and organ damage that occurs in lupus.
“The roots of the Lupus Research Institute are grounded in our mission to advance discovery and directly impact the future of lupus research, not only by increasing the number of studies conducted, but by influencing how new mechanisms and facets of the disease are researched,” said LRI President Margaret G. Dowd. “At the Lupus Research Institute, the status quo is never enough – we drive ourselves to discover new approaches to treating and curing a disease that has long been overlooked, ignored, and largely forgotten.”
Over the last decade, the LRI’s scientific strategy has delivered research progress and hope to the more than 1.5 million Americans living with lupus. With nearly $34 million invested in lupus research to date, and more than $100 million leveraged in follow-on funding from the National Institutes of Health and other organizations, the LRI supports the largest number, widest scope and most productive portfolio of new scientific knowledge in lupus research.
“The Lupus Research Institute’s documented discoveries are among the most pivotal in lupus, spanning multiple organ systems and molecular aspects of the disease,” said Michel Nussenzweig, M.D., Ph.D., the Sherman Fairchild Professor at Rockefeller University and a co-chair of the LRI’s Novel Research Task Force. “In addition to successful and productive research, the Institute has leveraged additional investment in lupus research, attracted fresh talent to the field, and validated the power of bold innovation to drive discovery in a complex disease.”
This year’s class of LRI researchers builds on the organization’s achievements in its first decade, confirming that new ideas in lupus research emerge from a variety of places. The group includes promising young lupus scientists and leading international lupus experts as well as investigators from diverse backgrounds such as oncology, biophysics, biochemistry, dermatology, and crystallography.
Each $300,000 research grant was awarded after multiple rounds of highly-rigorous peer review by scientists on the LRI's Novel Review Task Force. Applicants were judged principally on novelty of the hypotheses, scientific quality, strength of approach, relevance to lupus, and likelihood of success.
The other LRI grant recipients in this round include:
The LRI also is inviting applications for its next round of Novel Research Grants. The deadline for this next round of applications is May 27, 2011. Interested researchers and scientists can visit http://www.lupusresearchinstitute.org/research/grant_application to learn more about the grant application process.
About the LRI
Lupus Research Institute